Yourgene Health Plc (YGEN.L) Comparison with companies in other sectors?

Yourgene Health Plc has a share price of 3.19B. You can analyze Yourgene Health Plc (YGEN.L) competitors across different market sectors through stock heatmaps.

What are YGEN.L's NET and operating margins?

Yourgene Health Plc (YGEN.L) operating margin is around -0.07, and net profit margin is approximately -0.05 as of the latest reports.

In what way does YGEN.L's earnings per share (EPS) trend reflect its financial momentum?

Yourgene Health Plc (YGEN.L) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Yourgene Health Plc is -0.51, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Yourgene Health Plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Yourgene Health Plc like P/E which is -1.94, P/B which is 0.11, and PEG which is -1.94. Compare them with sector averages to evaluate if the stock is priced fairly.

Yourgene Health Plc

YGEN.L•LSE

Healthcare

Medical - Diagnostics & Research

£0.51

£-0.00(-0.47%)

Yourgene Health Plc (YGEN.L) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.01

P/E Ratio

-0.51

ROE

-0.06%

Net Margin

-0.05%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$16.37M

Shares OutstandingTotal number of shares issued

$3.19B

Book Value/ShareNet worth per share

$0.05

Revenue/ShareAnnual revenue per share

$0.05

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

-5.10%

Operating MarginOperating income as percentage of revenue

-6.76%

ROEReturn on shareholders' equity

-5.84%

ROAReturn on total assets

-2.99%

ROCEReturn on capital employed

-4.90%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.00

Cash/ShareCash and equivalents per share

$0.01

FCF YieldFree cash flow as percentage of market cap

-8.24%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for YGEN.LFinancial Ratios Analysis details for YGEN.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for YGEN.LSector Benchmarking details for YGEN.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Yourgene Health Plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Yourgene Health Plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Yourgene Health Plc's unique business strengths and challenges.

Key Financial Metrics for Yourgene Health Plc

For Yourgene Health Plc, essential financial indicators include EPS -0.01, PE -0.51, and ROE -0.06. These key ratios reveal insights into Yourgene Health Plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare Yourgene Health Plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Yourgene Health Plc

Metrics like Net Margin -5.10% and ROA -2.99% shed light on how well Yourgene Health Plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Yourgene Health Plc can sustain its operations and continue growing in the future.

Valuation and Market Position of Yourgene Health Plc

Using ratios such as P/B Ratio 0.11 and PEG Ratio -1.94, investors can assess whether Yourgene Health Plc is appropriately valued based on its financials and growth potential. These figures, combined with Yourgene Health Plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Yourgene Health Plc

Financial health indicators, such as Debt/Equity Ratio 0.58 and Cash Flow $-0.00, provide a snapshot of Yourgene Health Plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Yourgene Health Plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Yourgene Health Plc

Investing in Yourgene Health Plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Yourgene Health Plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;